Thirty eyes of 30 patients with BRVO of at least 6 weeks duration were randomized into three groups : Group 1 received a single dose of intravitreal Ranibizumab followed by grid laser treatment , Group 2 received a single dose of intravitreal Bevacizumab followed by grid laser treatment , and Group 3 received grid laser alone .